These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

473 related articles for article (PubMed ID: 32522677)

  • 21. Iron deficiency in pulmonary arterial hypertension associated with congenital heart disease.
    Yu X; Zhang Y; Luo Q; Liu Z; Zhao Z; Zhao Q; Gao L; Jin Q; Yan L
    Scand Cardiovasc J; 2018 Dec; 52(6):378-382. PubMed ID: 30632395
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic Value of Pulmonary Artery Compliance in Patients with Pulmonary Arterial Hypertension Associated with Adult Congenital Heart Disease.
    Cheng XL; Liu ZH; Gu Q; Ni XH; Luo Q; Zhao ZH; He JG; Xiong CM
    Int Heart J; 2017 Oct; 58(5):731-738. PubMed ID: 28966315
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma Connective Tissue Growth Factor as a Biomarker of Pulmonary Arterial Hypertension Associated With Congenital Heart Disease in Adults.
    Liu W; Hua Y; Zheng D; Lv W; Zhang W; Chen Q; Huang R; Li X
    Circ J; 2023 Mar; 87(4):527-535. PubMed ID: 36843115
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Baseline and Serial Brain Natriuretic Peptide Level Predicts 5-Year Overall Survival in Patients With Pulmonary Arterial Hypertension: Data From the REVEAL Registry.
    Frantz RP; Farber HW; Badesch DB; Elliott CG; Frost AE; McGoon MD; Zhao C; Mink DR; Selej M; Benza RL
    Chest; 2018 Jul; 154(1):126-135. PubMed ID: 29355551
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term effect of bosentan in pulmonary hypertension associated with complex congenital heart disease.
    Baptista R; Castro G; da Silva AM; Monteiro P; Providência LA
    Rev Port Cardiol; 2013 Feb; 32(2):123-9. PubMed ID: 23351920
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical and Instrumental Characteristics of Newly Diagnosed Patients with Various Forms of Pulmonary Hypertension according to the Russian National Registry.
    Chazova IY; Martynyuk TV; Valieva ZS; Gratsianskaya SY; Aleevskaya AM; Zorin AV; Nakonechnikov SN
    Biomed Res Int; 2020; 2020():6836973. PubMed ID: 32626754
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pulmonary Arterial Hypertension in Indonesia: Current Status and Local Application of International Guidelines.
    Dinarti LK; Anggrahini DW; Lilyasari O; Siswanto BB; Hartopo AB
    Glob Heart; 2021 Apr; 16(1):23. PubMed ID: 34040936
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blood biomarkers and their potential role in pulmonary arterial hypertension associated with congenital heart disease. a systematic review.
    Giannakoulas G; Mouratoglou SA; Gatzoulis MA; Karvounis H
    Int J Cardiol; 2014 Jul; 174(3):618-23. PubMed ID: 24814894
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pulmonary hypertension in adults with congenital heart disease: First data from Latvian PAH registry.
    Skride A; Sablinskis K; Lejnieks A; Rudzitis A
    Eur J Intern Med; 2016 Dec; 36():e20-e21. PubMed ID: 27637857
    [No Abstract]   [Full Text] [Related]  

  • 30. Pregnancy in Congenital Heart Disease, Complicated by Pulmonary Arterial Hypertension-A Challenging Issue for the Pregnant Woman, the Foetus, and Healthcare Professionals.
    Rudienė V; Kaplerienė L; Jančauskaitė D; Meškėnė E; Palevičiūtė E; Laukytė-Slėnienė M; Gasiūnaitė D; Ramašauskaitė D; Jurevičienė E; Gumbienė L
    Medicina (Kaunas); 2022 Mar; 58(4):. PubMed ID: 35454315
    [No Abstract]   [Full Text] [Related]  

  • 31. Circulating High Mobility Group Box-1 Does Not Predict Pulmonary Arterial Hypertension in Children with Congenital Heart Disease: A Prospective Cohort Study.
    Caracci B; Pehora C; Benson L; Steinberg BE; Goldenberg NM; Taylor K
    J Cardiothorac Vasc Anesth; 2024 Oct; 38(10):2356-2361. PubMed ID: 39095209
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Consistent Effectiveness and Safety of Macitentan Therapies Across Idiopathic and Congenital Heart Disease-Associated PulmonaryArterial Hypertension: A Single-Center Experience.
    Kaymaz C; Tanyeri S; Tokgöz HC; Akbal ÖY; Karagöz A; Keskin B; Kültürsay B; Hakgör A; Külahçıoğlu Ş; Bayram Z; Efe SÇ; Tanboğa İH; Doğan C; Akbulut M; Özdemir N
    Anatol J Cardiol; 2022 Oct; 26(10):778-787. PubMed ID: 36196862
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pulmonary Hypertension in Adults with Congenital Heart Disease: Real-World Data from the International COMPERA-CHD Registry.
    Kaemmerer H; Gorenflo M; Huscher D; Pittrow D; Apitz C; Baumgartner H; Berger F; Bruch L; Brunnemer E; Budts W; Claussen M; Coghlan G; Dähnert I; D'Alto M; Delcroix M; Distler O; Dittrich S; Dumitrescu D; Ewert R; Faehling M; Germund I; Ghofrani HA; Grohé C; Grossekreymborg K; Halank M; Hansmann G; Harzheim D; Nemes A; Havasi K; Held M; Hoeper MM; Hofbeck M; Hohenfrost-Schmidt W; Jurevičienė E; Gumbienè L; Kabitz HJ; Klose H; Köhler T; Konstantinides S; Köestenberger M; Kozlik-Feldmann R; Kramer HH; Kropf-Sanchen C; Lammers A; Lange T; Meyn P; Miera O; Milger-Kneidinger K; Neidenbach R; Neurohr C; Opitz C; Perings C; Remppis BA; Riemekasten G; Scelsi L; Scholtz W; Simkova I; Skowasch D; Skride A; Stähler G; Stiller B; Tsangaris I; Vizza CD; Vonk Noordegraaf A; Wilkens H; Wirtz H; Diller GP; Grünig E; Rosenkranz S
    J Clin Med; 2020 May; 9(5):. PubMed ID: 32414075
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A cross-sectional study of pulmonary arterial hypertension in congenital heart disease by right heart catheterization].
    Li W; Sun Y; Pang K; Wang H; Yang T; Gu Q; Zhao Z; Xiong C; Ni X; Liu Z; He J
    Zhonghua Yi Xue Za Zhi; 2014 Aug; 94(32):2485-9. PubMed ID: 25410917
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mortality in pulmonary arterial hypertension due to congenital heart disease: Serial changes improve prognostication.
    Schuijt MTU; Blok IM; Zwinderman AH; van Riel ACMJ; Schuuring MJ; de Winter RJ; Duijnhouwer AL; van Dijk APJ; Mulder BJM; Bouma BJ
    Int J Cardiol; 2017 Sep; 243():449-453. PubMed ID: 28606655
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk assessment and survival of patients with pulmonary hypertension: Multicenter experience in Turkey.
    Yaylalı YT; Başarıcı I; Kılıçkıran Avcı B; Meriç M; Sinan ÜY; Şenol H; Küçükoğlu MS; Öngen Z
    Anatol J Cardiol; 2019 Jun; 21(6):322-330. PubMed ID: 31142721
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pulmonary arterial hypertension in a multi-ethnic Asian population: Characteristics, survival and mortality predictors from a 14-year follow-up study.
    Lim Y; Low TT; Chan SP; Teo TW; Jang JJ; Yip N; Kuntjoro I; Tay EL; Yip JW
    Respirology; 2019 Feb; 24(2):162-170. PubMed ID: 30180305
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Utility of B-type natriuretic peptides in the assessment of patients with systemic sclerosis-associated pulmonary hypertension in the PHAROS registry.
    Chung L; Fairchild RM; Furst DE; Li S; Alkassab F; Bolster MB; Csuka ME; Derk CT; Domsic RT; Fischer A; Frech TM; Gomberg-Maitland M; Gordon JK; Hinchcliff M; Hsu V; Hummers LK; Khanna D; Medsger TAJ; Molitor JA; Preston IR; Schiopu E; Shapiro L; Hant F; Silver R; Simms R; Varga J; Steen VD; Zamanian RT
    Clin Exp Rheumatol; 2017; 35 Suppl 106(4):106-113. PubMed ID: 27908301
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Survival of Left-to-Right Shunt Repair in Children with Pulmonary Arterial Hypertension at a Tertiary Hospital in a Low-to-Middle-Income Country.
    Arafuri N; Murni IK; Idris NS; Uiterwaal CSPM; Savitri AI; Nugroho S; Noormanto N
    Glob Heart; 2021 Apr; 16(1):25. PubMed ID: 34040938
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current era survival of patients with pulmonary arterial hypertension associated with congenital heart disease: a comparison between clinical subgroups.
    Manes A; Palazzini M; Leci E; Bacchi Reggiani ML; Branzi A; Galiè N
    Eur Heart J; 2014 Mar; 35(11):716-24. PubMed ID: 23455361
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.